Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements (English, HTML)

View metadata and access the original English HTML file: Guidance for market authorization requirements for COVID-19 vaccines: Quality, manufacturing and lot release requirements.

Format

HTML

Access

file-only

Publisher-reported update

2022-07-28

This document provides guidance on establishment licensing, product quality and lot release to bring a COVID-19 vaccine to market in Canada.

Access original file